Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-13

Clinical Trial Update: Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating bioavailability and the effect of food on the original gelatin formulation and two new formulations of afuresertib in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afuresertib (afuresertib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 1 | Status: COMPLETED